T he treatment of deep venous thrombosis (DVT) is primarily directed at the prevention of propagation of the thrombus and of the occurrence of life-threatening pulmonary emboli. Venous valvular incompetence caused by valve destruction or venous hypertension is thought to be responsible for late venous insufficiency associated with the disabling postthrombotic clinical manifestations of pain, leg edema, ulceration, and hyperpigmentation.'-6 The use of heparin alone has been of significant benefit in decreasing the mortality of DVT-induced pulmonary embolism7 but has been of limited value in lysis of thrombi. Thrombolytic therapy has been shown to be more successful in thrombus resolution when compared with standard heparin treatment8 9 and may preserve venous valvular function and prevent postthrombotic sequelae. 10 Follow-up studies of DVT documented in the literature are primarily based on repeat phlebographic exam-inations carried out at various intervals ranging from months to years, and different rates of thrombus resolution and recanalization are reported.3"1 '-15 Duplex scanning, combining B-mode imaging and Doppler measurements, is presently gaining wide acceptance as the noninvasive test of choice in the diagnosis of DVT of the lower extremity. 16 The experience with duplex scanning gained in our vascular laboratory has been reported recently. 17 The aim of the present prospective follow-up study was to assess the spontaneous regression of thrombi in patients with acute femoropopliteal thrombosis treated with heparin. Two main questions were addressed: 1) What is the rate of change over time? 2) 
Results
The study population consisted of 18 patients with an established diagnosis of lower limb DVT. In two patients, thrombosis was present in two legs. Four segments were studied in each affected leg. The distribution of thrombosis in the study population at diagnosis is shown in Figure 1 . Thrombosis was present in 49 of 80 vein segments and was distributed as follows: common Common Femoral Vein At diagnosis, thrombosis was present in 10 of 20 segments studied. Seven segments were rated as score 2 and three segments as score 1. Six of the seven occluded segments (score 2) recanalized. Residual lesions at 6 months were seen in seven of 10 segments. The frequency distribution of the thrombosis scores 0, 1, and 2 at various intervals is shown in Figure 2 . Thrombus propagation was seen in five patients in the 6-month period (Table 1) . In one case, this occurred in a previously affected segment. In the other four cases, fresh thrombus was observed in the previous patent vein segment, leading to occlusion in two patients. The Markov matrices depicting the frequency-shift of the thrombosis scores 0, 1, and 2 per interval are presented in Table 2 . A comparison between the matrices showed no significant difference in the pattern of change beThe PFV was the initially least affected segment. At diagnosis, three of the 20 segments had a thrombosis score of 2, two were rated as score 1, and the other 15 were not affected (score 0). All three occluded segments recanalized ( Figure 2) . Residual lesions at 6 months were seen in two of five affected segments. Thrombus propagation occurred in two patients during the first 
so n r T Table 3 . The decrease in thrombus load was significant (p<0.001) and showed an exponential rate of change similar to the CFV.
Superficial Femoral Vein
At diagnosis, thrombosis was seen in 16 of 20 segments studied. Eleven segments were rated as score 2, and five had a score of 1. Recanalization occurred in eight of 11 segments, whereas residual lesions were seen in 12 of 16 affected segments (Figure 2 ). Propagation of thrombus was seen in one patient; during the first week, a partially occluding thrombus occurred in a previously unaffected segment. 
Popliteal Vein
The PV segment was the initially most affected segment. Thrombosis was diagnosed in 18 of 20 segments. Ten segments had a score of 2; eight were rated as score 1. Recanalization occurred in six of 10 occluded segments ( Figure 2 ). Residual lesions were seen in 11 of 18 affected segments. Extension of thrombosis was seen in seven segments. A significant exponential decline (p<O.OOl) in thrombus load was observed (Table 5) Figure 2C . Recanalization progressed at a similar rate in the four vein segments under study (p<0.001). In 20 of 23 segments (87%), recanalization occurred within 6 weeks after diagnosis.
Propagation of thrombus was observed in 15 vein segments and could neither be related to the individual vein segment (p=0.23) nor to the initial thrombosis score (p=0.1) of the affected segments. Thrombus propagation occurred in four previously affected segments (Table 1) , whereas extension into proximal or distal segments was observed in 11 cases. Increase in thrombus, whether in previously affected or unaffected vein segments, was limited in all except one case to a one-point increase of the thrombosis score. In none of the patients was extension of thrombus associated with clinical evidence of embolic sequelae. In only two cases, proximal extension of thrombosis resulted in subsegmental occlusion of a previous patent common femoral vein.
Laboratory studies identified two patients with protein C and protein S deficiency, respectively, and one patient with a circulating lupus anticoagulant. In two more patients, recurrent thrombosis was present. The frequency of thrombus propagation in this subgroup of patients was not different (p=0.9) from the other patients.
Discussion
The standard treatment of DVT is anticoagulation with intravenous heparin, which itself has no fibrinolytic activity but prevents further coagulation while allowing the body's natural thrombolytic system to act on the existing clot. In vivo studies in humans have described substantial resolution of pulmonary emboli within hours to days after embolization.23'24 The mechanism of canalization of thrombus in DVT of the lower extremity was excellently described by Cox25 and Sevitt,26 but no mention was made of the rate of thrombolysis in different vein segments. Lea-Thomas and McAllister14 found recanalization to be more frequent in calf vein thrombosis than femoral vein thrombosis, whereas Bergvall and Hjelmstedt1" reported the opposite with better recanalization in proximal vein thrombosis. Recanalization, according to the literature,3 1-is considered a late reaction occurring in up to 70% of affected limbs in periods ranging from 6 months to many years.
Our study showed an exponential thrombus regression rate equal for all vein segments of the thigh, despite a significant difference in initial thrombus load between the different vein segments. The amount of residual disease, although considerable in individual segments (SFV, PV) and the degree of recanalization, are therefore merely a function of the initial thrombus load and are not specifically segment related. The process of recanalization was shown to be confined mainly to the first 6 weeks after thrombosis and showed little progression afterward. Our observations confirm the report by Killewich et al,27 which showed recanalization of thrombus in lower-limb DVT not to be the slow process suggested in the past."1-14
Few studies27-30 to date have used B-mode or duplex scanning in the assessment of the natural history of DVT. Our study is the first to describe thrombus regression in different vein segments in a quantitative manner using duplex scanning in combination with a thrombosis scoring system,'8 which avoids subjective estimation of treatment results and allows the comparison of different patient groups over time. Our data provide a baseline regarding thrombus regression in heparin-treated DVT and may act as reference in the evaluation of other treatment regimens, i.e., thrombolysis.
Our study was limited to the femoropopliteal vein segment by the use of a conventional duplex scanner. The accuracy of conventional duplex scanning for diagnosing clinically suspected DVT of the femoropopliteal veins is well established,73' but the ability to detect matic.32 Color-flow imaging facilitates the identification of vascular structures, especially of the infrapopliteal veins,33 and its application will allow further study of proximal and distal vein segments.
The natural course of venous thrombosis is threefold34; the initial loose thrombus becomes adherent to the vein wall by the end of the first week. The local inflammatory response of the vessel wall initiates the organization of thrombus with subsequent contraction, and spontaneous lysis of areas within the thrombus finally leads to recanalization. Thrombus regression as defined in our study reflects the overall outcome of these processes. Clearance of thrombus is a gradual process, which on B-mode imaging is depicted by an increase in vein wall compressibility. The Doppler flow measurements show a gradual change from no flow in the totally occluded segment, through augmentable flow on distal compression and continuous flow in the partially obstructed lumen, to a return of phasic flow in the segment with fully regained patency. Duplex scanning cannot differentiate whether the changes are due to lysis or organization. However, recanalization of an occluded vein segment, defined in our study by a change in thrombosis score from 2 to <2 at all times and by definition represents true lysis, either alone or in combination with retraction and organization.
In our opinion, B-mode imaging and Doppler measurements are equally important in the follow-up of DVT by duplex scanning. Vessel wall compressibility with B-mode will exclude thrombosis or indicate thrombus resolution in previously affected areas, whereas the Doppler examination is essential in differentiating between patency and partial or total obstruction of the vessel lumen.
If one considers the development of late venous insufficiency to be the result of direct damage to the valve cusps by thrombus,' the more severe thrombotic insult in vein segments showing a higher percentage of residual lesions might be expected to induce more late valvular incompetence in these segments. The development of reflux after DVT will be the subject of a separate report.
Propagation of thrombus at different intervals during treatment found in a number of patients in our study has been reported by others.29303536 An increase in the thrombosis score in partially occluded vein segments (thrombosis score of 1) within the first weeks after diagnosis may in part reflect a progressive occlusion of the vein lumen caused by increased thrombus adherence and retraction; however, extension into previously unaffected segments represents true addition of thrombus to the existing load. An increase of thrombus might suggest the inadequacy of our current treatment protocol for continuous heparin infusion therapy or insufficient monitoring of the plasma prothrombin time in coumarin-treated outpatients. In a recent study, Krup- ski et a130 reported propagation of thrombus in one third of nine adequately anticoagulated patients, thus indicating that thrombus propagation is not necessarily synonymous with treatment failure. It seems likely, therefore, that although the level of anticoagulation in a patient can be satisfactory, the effectiveness of the anticoagulant on the thrombus may vary, depending on local factors such as the degree of occlusion of the vein and thrombi in the calf and iliac vein area is more problethe presence of collaterals. Other possible explanations of thrombus propagation include heparin-induced thrombocytopenia, which in our patients could be rejected on clinical grounds, and heparin-induced inhibition of endogenous fibrinolysis. If the latter were true, the occurrence could only be incidental; otherwise, its effect would have been shown as a generalized increase in the early thrombosis scores.
Thrombus propagation could not be related in our study to factors associated with recurrent thromboembolism such as a history of DVT or prethrombotic conditions.
The increase in thrombus remains a puzzling phenomenon of which the clinical significance remains as yet unclear. Thrombus propagation in our study was minor in 96% of the cases, with an increase of the thrombosis score of one point only in all except one case. Moreover, propagation did not influence the outcome in our patients, as no clinical evidence of embolic sequelae was found.
Conclusions
The results of our study do not justify a plea for a more aggressive treatment of DVT or a more intensive monitoring of patients during follow-up. Our study unequivocally shows, however, the potential of duplex scanning in the follow-up of individual patients and the possibility to define patients with aggressive extension of thrombus. As a research tool, duplex scanning may help to identify factors associated with rethrombosis and provide the opportunity to assess new therapeutic agents in the treatment of DVT in greater detail through sequential studies without unnecessary discomfort to the patient.
